org placeholder image

Matthew Giles

Director, Qc and Ar&D at Elite Pharmaceuticals

  • LinkedIn

Email Email: m****@primera-corp.com

phone noPhone Number: (***)-***-****

Accomplished analytical chemist with success as a consultant, and business leader, who is highly proficient in chromatographic method development, analytical development, regulatory/quali...

Read More

map
ELITE PHARMACEUTICALS

ELITE PHARMACEUTICALS

  • description Description
    Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 25 Million to 50 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Elite Pharmaceuticals Org Chart and Mapping

Employees

Frequently Asked Questions Regarding Matthew Giles

Answer: Matthew Giles works for Elite Pharmaceuticals as Director, Qc and Ar&D

Answer: Matthew Giles’s role in Elite Pharmaceuticals is Director, Qc and Ar&D

Answer: Matthew Giles's email address is m***@gmail.com

Answer: Matthew Giles's business email address is m****@primera-corp.com

Answer: Matthew Giles’s direct phone number is (***)-***-****

Answer: Matthew Giles works in the industry of: Pharmaceuticals

Answer: Matthew Giles is the current Director, Qc and Ar&D at Elite Pharmaceuticals.... Read More

Answer: Matthew Giles works Elite Pharmaceuticals located at Lincoln St, Oak Park, , 48237, Michigan, 14511, United States

Answer: Elite Pharmaceuticals's Director, Qc and Ar&D is Matthew Giles

Answer: Matthew Giles contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@primera-corp.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access